Outcome Measures for Psoriasis Severity: A Report from the GRAPPA 2012 Annual Meeting

被引：8

作者：

Duffin, Kristina Callis ^{[1
]}

Gottlieb, Alice B. ^{[2
]}

机构：

[1] Univ Utah, Dept Dermatol, Salt Lake City, UT USA

[2] Tufts Med Ctr, Boston, MA USA

来源：

JOURNAL OF RHEUMATOLOGY | 2013年 / 40卷 / 08期

关键词：

PSORIASIS; PSORIATIC ARTHRITIS; OUTCOME MEASURES; PHYSICIAN GLOBAL ASSESSMENT; OMERACT; GLOBAL ASSESSMENT; TRIALS; INDEX; AREA;

D O I：

10.3899/jrheum.130454

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

At the 2012 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) in Stockholm, Sweden, dermatology members provided summaries of ongoing work with outcome measures for psoriasis severity. Controversies around the physician global assessment (PGA) were summarized, including discussions of variations and limitations of the static PGA instruments in use. The Psoriasis Outcome Measures project was introduced, with a goal of developing measures for use in clinical trials and practice. This project will follow the Outcome Measures in Rheumatology (OMERACT) process and may become a model for outcome measures of other dermatologic diseases.

引用

页码：1423 / 1424

页数：2

共 10 条

[1]

[Anonymous], 1998, DERM OPHTH DRUGS ADV

[2] SEVERE PSORIASIS - ORAL THERAPY WITH A NEW RETINOID [J].

FREDRIKSSON, T ;

PETTERSSON, U .

DERMATOLOGICA, 1978, 157 (04) :238-244

[3] Dermatology Screening Tools: Project Update from the GRAPPA 2012 Annual Meeting [J].

Gladman, Dafna D. ;

Helliwell, Philip S. ;

Khraishi, Majed ;

Duffin, Kristina Callis ;

Mease, Philip J. .

JOURNAL OF RHEUMATOLOGY, 2013, 40 (08) :1425-1427

[4] Psoriasis Outcome Measures: A Report from the GRAPPA 2012 Annual Meeting [J].

Gottlieb, Alice B. ;

Armstrong, April W. .

JOURNAL OF RHEUMATOLOGY, 2013, 40 (08) :1428-1433

[5] Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician's global assessment [J].

Langley, RG ;

Ellis, CN .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (04) :563-569

[6] Comparators, study duration, outcome measures and sponsorship in therapeutic trials of psoriasis: update of the EDEN Psoriasis Survey 2001-2006 [J].

Naldi, L. ;

Svensson, A. ;

Zenoni, D. ;

Diepgen, T. ;

Elsner, P. ;

Grob, J. -J. ;

Coenraads, P. -J. ;

Bavinck, J. N. Bouwes ;

Maccagni, A. ;

Linder, D. ;

Williams, H. .

BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (02) :384-389

[7]

OMERACT, INT CONS C OUTC MEAS

[8] Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis [J].

Robinson, Amanda ;

Kardos, Marisa ;

Kimball, Alexandra B. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (03) :369-375

[9] How Good Are Clinical Severity and Outcome Measures for Psoriasis?: Quantitative Evaluation in a Systematic Review [J].

Spuls, Phyllis I. ;

Lecluse, Lidian L. A. ;

Poulsen, Marie-Louise N. F. ;

Bos, Jan D. ;

Stern, Robert S. ;

Nijsten, Tamar .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 (04) :933-943

[10] OMERACT: An international initiative to improve outcome measurement in rheumatology [J].

Tugwell, Peter ;

Boers, Maarten ;

Brooks, Peter ;

Simon, Lee ;

Strand, Vibeke ;

Idzerda, Leanne .

TRIALS, 2007, 8 (1)

← 1 →